PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19593677-15	2009	IMPA1 is regulated by another calcium-binding protein calbindin-D28k (CaB), since we reported earlier that the CaB levels are reduced in SCA1 PCs, the activation of IMPA1 by S100B may modulate CaB-dependent inositol signaling.	Inositol	207-215	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	0-5	
19593677-15	2009	IMPA1 is regulated by another calcium-binding protein calbindin-D28k (CaB), since we reported earlier that the CaB levels are reduced in SCA1 PCs, the activation of IMPA1 by S100B may modulate CaB-dependent inositol signaling.	Inositol	207-215	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	165-170	
17460611-8	2008	In conclusion the IMPA1-/- mouse represents a novel model to study inositol homeostasis, and indicates that genetic inactivation of IMPA1 can mimic some actions of lithium.	Inositol	67-75	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	18-23	
21246399-4	2011	Two independent mechanisms may result in fetal myo-inositol deficiency: competitive inhibition of the inositol monophosphatase1 (IMPA1)-mediated hydrolysis of inositol monophosphate by high galactose-1- phosphate levels leading to a sequestration of cellular myo-inositol as inositol monophosphate and galactitol-induced reduction in SMIT1-mediated myo-inositol transport.	Inositol	47-59	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	102-127	
12877981-11	2003	The fact that lithium treatment upregulates both MIP synthase and IMPA1 mRNA levels in mouse hippocampus may reflect a compensatory response of both genes to inositol depletion.	Inositol	158-166	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	66-71	
27922641-6	2016	Inositol metabolites were differently affected by IMPA1 and SMIT1 knockout.	Inositol	0-8	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	50-55	
25679134-8	2015	Inositol-deficient food-treated animals, both lithium treated and with inositol monophosphatase 1 knockout, had significantly elevated cholinergic behavior rating and significantly increased or earlier seizures compared with the controls.	Inositol	0-8	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	71-97	
21246399-4	2011	Two independent mechanisms may result in fetal myo-inositol deficiency: competitive inhibition of the inositol monophosphatase1 (IMPA1)-mediated hydrolysis of inositol monophosphate by high galactose-1- phosphate levels leading to a sequestration of cellular myo-inositol as inositol monophosphate and galactitol-induced reduction in SMIT1-mediated myo-inositol transport.	Inositol	47-59	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	129-134	
21246399-4	2011	Two independent mechanisms may result in fetal myo-inositol deficiency: competitive inhibition of the inositol monophosphatase1 (IMPA1)-mediated hydrolysis of inositol monophosphate by high galactose-1- phosphate levels leading to a sequestration of cellular myo-inositol as inositol monophosphate and galactitol-induced reduction in SMIT1-mediated myo-inositol transport.	Inositol	259-271	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	102-127	
21246399-4	2011	Two independent mechanisms may result in fetal myo-inositol deficiency: competitive inhibition of the inositol monophosphatase1 (IMPA1)-mediated hydrolysis of inositol monophosphate by high galactose-1- phosphate levels leading to a sequestration of cellular myo-inositol as inositol monophosphate and galactitol-induced reduction in SMIT1-mediated myo-inositol transport.	Inositol	259-271	inositol (myo)-1(or 4)-monophosphatase 1	Mus musculus	129-134